 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Eric Pietras and Sweta Patel.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.277 |
|
|
|
-
Patel SB, Moskop DR, Moreira S, Gipson S, Anderson CC, Crook A, McCabe M, Stephenson D, Terry HE, Kent A, Young TN, Krug AE, Thomas CI, Price C, Ransom M, Miller R, Vujovic A, Minhajuddin M, Althoff MJ, Consortium TC, Saviola AJ, Stevens BM, Welner RS, Andrianova EL, Gudkov AV, Darehshouri A, Reisz JA, Nemkov T, D'Alessandro A, Gillen AE, Pollyea DA, Jordan CT, Pietras EM. The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells. Blood Cancer Discov. 2026 Jul 21.
Score: 0.998
-
Patel SB, Moskop D, Moriera S, Gipson S, Anderson CC, Crook A, McCabe M, Stephenson D, Terry HE, Kent A, Young T, Krug A, Price C, Ransom M, Miller R, Vujovic A, Minhajuddin M, Althoff MJ, Saviola AJ, Stevens BM, Welner RS, Andrianova EL, Gudkov AV, Nemkov T, D Alessandro A, Gillen AE, Pollyea DA, Jordan CT, Pietras EM. The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells. bioRxiv. 2025 Dec 22.
Score: 0.959
-
Patel SB, Moskop DR, Jordan CT, Pietras EM. Understanding MDS stem cells: Advances and limitations. Semin Hematol. 2024 12; 61(6):409-419.
Score: 0.880
-
Patel SB, Pietras EM. B cells regulate hematopoietic stem cells via cholinergic signaling. Nat Immunol. 2022 04; 23(4):476-478.
Score: 0.740
-
Niño KE, Adema V, Gray AE, Cowan CM, Schleicher WE, Hosseini M, Bennett SN, Patel SB, Moreira S, Danis E, Ma F, Lin HY, Young TN, Anderson CA, Sharma D, Varesi A, Filippi MD, Ito K, Dawlaty MM, Huang G, Reisz JA, Xie SZ, Chan SM, Tan L, Garcia-Manero G, Chien K, Gomez IG, D'Alessandro A, Colla S, Pietras EM. Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cells. bioRxiv. 2026 Mar 02.
Score: 0.243
-
Pollyea DA, Stevens BM, Abbott D, Amaya M, Gutman JA, Kent A, McMahon C, Schwartz M, Smith C, Dell-Martin J, Sohalski C, Ellis A, Haag M, Schowinsky J, Pan Z, Patel SB, Ransom M, Gillen A, Jordan CT, Pietras EM. Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial. EClinicalMedicine. 2025 Nov; 89:103546.
Score: 0.236
-
Mills TS, Kain B, Burchill MA, Danis E, Lucas ED, Culp-Hill R, Cowan CM, Schleicher WE, Patel SB, Tran BT, Cao R, Goodspeed A, Ferrara S, Bevers S, Jirón Tamburini BA, Roede JR, D'Alessandro A, King KY, Pietras EM. A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice. Cell Stem Cell. 2024 Nov 07; 31(11):1630-1649.e8.
Score: 0.221
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|